Complete Filing Data
Grupo Aval Acciones Y Valores S.A. reported Cash And Cash Equivalents of $17.00 trillion for FY2024.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Grupo Aval Acciones Y Valores S.A. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue From Interest | $28.18T | $28.92T | $19.40T | $12.79T | $13.22T | $19.55T | $18.36T | $18.74T | $17.55T | $14.08T |
| Profit Loss Before Tax | $3.14T | $3.49T | $6.27T | $6.36T | $4.84T | $7.45T | $7.33T | $4.92T | $5.57T | $5.22T |
| Profit Loss Attributable To Owners Of Parent | $1.02T | $739.00B | $2.48T | $3.30T | $2.35T | $3.03T | $2.91T | $1.96T | $2.14T | $2.04T |
| Profit Loss Attributable To Noncontrolling Interests | $1.18T | $1.44T | $2.39T | $2.37T | $2.28T | $2.33T | $2.27T | $1.20T | $1.38T | $1.30T |
| Profit Loss | $2.19T | $2.18T | $4.87T | $5.67T | $4.63T | $5.37T | $5.18T | $3.16T | $3.52T | $3.35T |
| Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss Net Of Tax | $288.02B | $103.60B | -$410.85B | -$79.26B | $198.58B | $185.86B | -$129.15B | -$76.15B | -$26.71B | -$1.09B |
| Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Net Of Tax | $458.12B | $458.93B | -$2.75T | $532.02B | -$427.89B | $515.87B | -$80.60B | $151.52B | $328.91B | $279.65B |
| Other Comprehensive Income | $746.13B | $562.53B | -$3.16T | $452.76B | -$229.31B | $701.73B | -$209.75B | $75.37B | $302.21B | $278.56B |
| Interest Revenue Expense | $7.27T | $6.29T | $7.74T | $12.73T | $11.96T | $11.29T | $10.87T | $10.51T | $9.15T | $8.32T |
| Interest Income After Impairment Losses | $3.08T | $2.10T | $5.25T | $5.41T | $3.13T | $7.53T | $7.07T | $6.66T | $6.37T | $6.38T |
| Interest Expense On Other Financial Liabilities | $5.72T | $6.42T | $3.91T | $2.02T | $2.22T | $2.75T | $2.34T | $2.38T | $2.58T | $1.92T |
| Interest Expense On Deposits From Customers | $15.19T | $16.21T | $7.76T | $2.64T | $3.58T | $5.51T | $5.14T | $5.85T | $5.81T | $3.83T |
| Income Taxes Paid Refund Classified As Operating Activities | $2.01T | $1.97T | $1.54T | $1.75T | $1.75T | $1.61T | $1.47T | $1.47T | $791.34B | $519.54B |
| Income Tax Relating To Components Of Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss | $12.48B | -$5.50B | $67.98B | $35.25B | -$5.18B | -$4.01B | $13.08B | -$24.08B | -$14.52B | $7.25B |
| Income Tax Relating To Components Of Other Comprehensive Income That Will Be Reclassified To Profit Or Loss | -$238.68B | $818.73B | $1.93T | -$1.09T | -$452.01B | $40.04B | -$323.14B | $97.70B | $378.88B | -$1.21T |
| Income Tax Expense Continuing Operations | $946.43B | $1.31T | $2.27T | $2.32T | $1.36T | $2.09T | $2.15T | $1.75T | $2.06T | $1.88T |
| Impairment Loss On Loan And Other Accounts Receivable | $4.76T | $4.75T | $3.12T | $3.19T | $4.59T | $4.19T | $4.15T | $4.12T | $3.00T | $2.13T |
| Impairment Loss | $4.19T | $4.18T | $2.49T | $2.72T | $4.28T | $3.76T | $3.80T | $3.85T | $2.78T | $1.94T |
| Comprehensive Income Attributable To Owners Of Parent | $1.32T | $1.34T | $219.14B | $3.55T | $2.12T | $3.43T | $2.78T | $2.00T | $2.35T | $2.21T |
| Comprehensive Income Attributable To Noncontrolling Interests | $1.62T | $1.40T | $1.49T | $2.57T | $2.28T | $2.64T | $2.20T | $1.24T | $1.47T | $1.42T |
| Comprehensive Income | $2.94T | $2.74T | $1.71T | $6.12T | $4.40T | $6.07T | $4.97T | $3.24T | $3.82T | $3.62T |
| Adjustments For Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss | $4.83T | $4.80T | $3.18T | $4.55T | $6.31T | $4.24T | $4.17T | $4.14T | $3.01T | $2.13T |
| Revenue From Sale Of Goods And Rendering Of Services | $11.05T | $11.22T | $12.14T | $10.45T | $9.14T | $9.16T | $8.13T | $5.79T | $6.65T | |
| Impairment Recovery On Other Financial Assets | $4.16B | -$12.87B | $16.72B | $660.0M | $16.83B | -$60.02B | -$32.51B | $142.0M | $70.41B | |
| Cost Of Merchandise Sold And Service Expenses | $8.57T | $8.01T | $7.60T | $7.35T | $6.32T | $6.78T | $5.48T | $5.04T | $5.73T |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Cash Equivalents | $17.00T | $18.60T | $17.03T | $36.64T | $34.03T | $30.12T | $28.40T | $22.34T | $22.19T | $22.28T | $17.27T |
| Purchase Of Property Plant And Equipment Classified As Investing Activities | $636.10B | $589.07B | $519.37B | $664.51B | $638.26B | $679.02B | $548.98B | $473.75B | $814.56B | $920.45B | |
| Purchase Of Intangible Assets Classified As Investing Activities | $658.59B | $683.46B | $598.18B | $569.92B | $558.98B | $377.47B | $389.15B | $268.76B | $183.66B | $353.63B | |
| Purchase Of Biological Assets | $26.57B | $26.12B | $28.37B | $27.21B | $21.29B | $20.56B | $20.90B | $24.41B | $21.43B | $35.27B | |
| Interest Income On Debt Instruments Held | $2.72T | $2.39T | $1.84T | $909.27B | $758.03B | $1.06T | $966.02B | $841.87B | $881.45B | $1.07T | |
| Goodwill | $2.22T | $2.20T | $2.25T | $8.49T | $7.71T | $7.35T | $7.32T | $6.90T | $6.82T | $7.06T | |
| Cash Flows From Used In Operating Activities | $782.29B | $6.01T | -$222.12B | $5.90T | $10.02T | $5.63T | $8.73T | $5.11T | $2.49T | $11.35T | |
| Cash Flows From Used In Investing Activities | -$3.14T | $1.84T | -$13.01T | -$6.60T | -$7.59T | -$3.06T | -$3.05T | -$3.61T | -$952.87B | -$6.75T | |
| Cash Flows From Used In Financing Activities | -$1.36T | -$3.54T | -$8.57T | -$1.35T | $404.45B | -$895.99B | -$997.56B | -$1.45T | $66.86B | -$2.81T | |
| Adjustments For Undistributed Profits Of Investments Accounted For Using Equity Method | $378.40B | $371.40B | $372.78B | $300.22B | $220.16B | $229.63B | $197.72B | $171.96B | $140.77B | $230.40B | |
| Adjustments For Losses Gains On Disposal Of Noncurrent Assets | -$21.50B | -$47.99B | -$9.69B | -$33.05B | -$108.62B | -$18.99B | -$14.86B | -$6.61B | -$20.66B | $10.35B | |
| Adjustments For Increase Decrease In Other Liabilities And Provisions | $1.09T | $1.43T | $462.87B | $1.91T | $246.97B | $143.13B | $2.76T | $283.04B | -$375.16B | -$634.73B | |
| Adjustments For Gain Loss On Fair Value Adjustment Financial Assets At Fair Value Through Profit Or Loss | -$4.66B | -$268.0M | -$76.0M | -$3.87B | -$1.35B | $2.30B | -$25.14B | -$37.82B | -$34.57B | $0.00 | |
| Adjustments For Decrease Increase In Trade Account Receivable | -$719.90B | -$975.73B | -$2.38T | -$617.75B | -$95.68B | -$374.44B | -$630.39B | -$804.97B | -$414.73B | -$1.05T | |
| Adjustments For Decrease Increase In Other Assets | -$136.82B | -$78.25B | $121.84B | -$316.89B | -$610.89B | -$283.19B | $13.71B | $177.65B | $207.86B | -$61.43B | |
| Noncurrent Assets Or Disposal Groups Classified As Held For Sale | $105.21B | $101.18B | $92.83B | $208.43B | $240.41B | $206.19B | $186.71B | $101.38B | $259.53B | $199.48B | $211.25B |
| Adjustments For Decrease Increase In Derivative Financial Assets | -$5.57T | -$2.76T | $545.50B | $696.85B | -$1.11T | -$584.60B | $709.40B | $2.32T | $3.10T |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Proceeds From Sales Or Maturity Of Financial Instruments Classified As Investing Activities | $8.33T | $8.22T | $6.40T | $6.59T | $4.28T | $3.64T | $3.81T | $3.37T | $2.66T | $2.80T |
| Proceeds From Sales Of Property Plant And Equipment Classified As Investing Activities | $78.50B | $76.70B | $72.99B | $76.73B | $41.91B | $77.07B | $56.35B | $69.79B | $241.60B | $194.29B |
| Proceeds From Sales Of Investment Property | $66.36B | $111.54B | $76.31B | $67.46B | $110.78B | $57.03B | $80.85B | $28.43B | $61.79B | $22.95B |
| Proceeds From Sales Of Biological Assets | $35.87B | $37.14B | $40.62B | $58.08B | $48.21B | $41.11B | $32.24B | $19.78B | $20.67B | $20.37B |
| Proceeds From Issue Of Bonds Notes And Debentures | $2.26T | $2.61T | $695.14B | $2.93T | $5.73T | $3.15T | $1.10T | $4.55T | $5.80T | $1.16T |
| Proceeds From Disposal Of Noncurrent Assets Or Disposal Groups Classified As Held For Sale And Discontinued Operations | $49.70B | $61.65B | $41.64B | $76.85B | $267.30B | $154.57B | $66.66B | $85.40B | $151.44B | $25.46B |
| Increase Decrease In Cash And Cash Equivalents | -$1.60T | $1.57T | -$19.61T | $2.62T | $3.91T | $1.72T | $6.06T | $143.83B | -$91.97B | $5.02T |
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | $2.12T | -$2.74T | $3.59T | $4.66T | $1.07T | $40.48B | $1.38T | $91.56B | -$1.69T | $3.21T |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Basic Earnings Loss Per Share | $42.75 | $31.12 | $107.29 | $148.01 | $105.45 | $136.19 | $130.73 | $88.08 | $96.04 | $91.62 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Provisions | $1.10T | $1.08T | $1.23T | $1.15T | $912.85B | $868.64B | $695.29B | $708.83B | $620.36B | $600.23B | $744.65B |
| Trading Income Expense | $1.40T | -$916.05B | $1.56T | $922.28B | $1.29T | $761.91B | $582.71B | $561.36B | $724.70B | $245.20B | |
| Repayments Of Bonds Notes And Debentures | $1.76T | $4.07T | $7.84T | $1.63T | $2.19T | $1.54T | $1.14T | $3.91T | $3.73T | $1.92T | |
| Purchase Of Investment Property | $793.0M | $163.0M | $2.27B | $876.0M | $1.66B | $2.37B | $54.41B | $75.82B | $56.61B | $75.46B | |
| Purchase Of Financial Instruments Classified As Investing Activities | $7.82T | $8.02T | $6.91T | $5.74T | $6.51T | $3.68T | $3.89T | $3.70T | $2.67T | $3.15T | |
| Other Expense By Nature | $8.65T | $8.35T | $7.41T | $6.79T | $6.32T | $10.17T | $9.37T | $9.00T | $8.57T | $7.61T | |
| Interest Received Classified As Operating Activities | $28.02T | $26.10T | $16.94T | $19.42T | $18.15T | $18.51T | $17.60T | $18.12T | $12.80T | $8.16T | |
| Interest Paid Classified As Operating Activities | $21.41T | $21.53T | $10.61T | $7.09T | $8.70T | $7.86T | $7.14T | $8.33T | $7.42T | $3.96T | |
| Fee And Commission Income Expense | $3.58T | $3.35T | $2.90T | $3.06T | $2.81T | $5.46T | $4.84T | $4.58T | $4.26T | $3.66T | |
| Fee And Commission Income | $4.62T | $4.36T | $3.87T | $3.80T | $3.45T | $6.08T | $5.45T | $5.20T | $4.88T | $4.28T | |
| Fee And Commission Expense | $1.03T | $1.00T | $970.68B | $731.74B | $635.71B | $628.00B | $613.76B | $623.11B | $619.53B | $621.95B | |
| Dividends Received Classified As Investing Activities | $445.60B | $477.57B | $411.37B | $368.96B | $389.65B | $307.57B | $206.55B | $171.42B | $125.35B | $79.26B | |
| Dividends Paid To Noncontrolling Interests Classified As Financing Activities | $667.33B | $915.93B | $615.18B | $913.36B | $946.03B | $804.30B | $745.93B | $768.77B | $743.91B | $882.52B | |
| Dividends Paid Classified As Financing Activities | $728.18B | $766.54B | $414.27B | $1.23T | $1.33T | $1.27T | $1.13T | $1.31T | $1.26T | $1.28T | |
| Adjustments For Unrealised Foreign Exchange Losses Gains | $454.82B | -$2.25T | $1.83T | -$87.24B | -$68.10B | $109.53B | $258.35B | -$98.98B | $248.00B | -$1.13T | |
| Adjustments For Increase Decrease In Employee Benefits | $49.20B | -$27.52B | $7.93B | -$8.39B | -$49.52B | -$93.99B | $42.62B | $46.51B | $45.14B | $299.0M | |
| Adjustments For Increase Decrease In Deposits From Customers | $14.82T | $15.35T | $17.84T | $6.92T | $24.61T | $10.41T | $3.97T | $11.46T | $9.67T | $8.59T | |
| Adjustments For Increase Decrease In Deposits From Banks | $3.33T | $5.88T | -$1.35T | $3.22T | -$2.67T | $2.36T | $1.71T | -$1.46T | -$3.40T | $4.87T | |
| Adjustments For Increase Decrease In Borrowings From Banks And Others | -$1.21T | -$4.11T | $9.13T | $3.51T | -$3.83T | -$3.20T | $1.48T | $514.47B | $146.66B | $1.44T | |
| Adjustments For Gains Losses On Fair Value Adjustment Investment Property | $35.84B | $84.96B | $55.93B | $22.78B | -$46.92B | $19.60B | $39.42B | $46.68B | $53.68B | $104.77B | |
| Adjustments For Gains Losses On Change In Fair Value Of Derivatives | $415.64B | -$2.58T | $1.53T | $798.19B | $669.31B | $142.08B | $427.21B | $164.92B | $228.08B | $74.11B | |
| Adjustments For Depreciation Expense | $588.29B | $557.06B | $559.88B | $886.95B | $921.71B | $839.11B | $478.61B | $463.89B | $455.85B | $391.78B | |
| Adjustments For Amortisation Expense | $686.34B | $594.11B | $530.63B | $559.40B | $479.88B | $459.58B | $478.57B | $437.82B | $323.68B | $384.24B | |
| Dividends Paid | $1.19T | $2.04T | $669.80B | $2.07T | $2.30T | $2.17T | $1.82T | $2.02T | $2.05T | -$2.18T | |
| Adjustments For Increase Decrease In Borrowings From Development Entities | -$240.50B | $408.02B | -$1.90B | -$1.68B | $9.12B | -$680.0M | -$2.23B | -$3.13B | -$13.33B | ||
| Gain On Recovery Of Loans And Advances Previously Written Off | $574.26B | $555.77B | $643.98B | $471.91B | $328.10B | $378.86B | $320.12B | $264.58B | $290.44B | ||
| Adjustments For Validation And Interest From Concession Agreements | -$2.85T | -$3.92T | -$5.14T | -$4.16T | -$3.74T | -$3.96T | -$3.18T | -$209.94B | -$180.98B | ||
| Adjustments For Dividend Income | $148.45B | $126.27B | $119.89B | $159.12B | $91.57B | $84.69B | $71.49B | $50.44B | $28.03B |
Most recent annual filing with the SEC: April 28, 2025
Data sourced from SEC EDGAR public filings as of August 5, 2026.